ESSA Pharma Inc (EPIX)
6.70
-0.28
(-4.01%)
USD |
NASDAQ |
May 07, 16:00
6.81
+0.11
(+1.64%)
After-Hours: 20:00
ESSA Pharma Cash from Operations (Quarterly): -6.787M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.787M |
| September 30, 2023 | -4.488M |
| June 30, 2023 | -3.324M |
| March 31, 2023 | -7.592M |
| December 31, 2022 | -4.377M |
| September 30, 2022 | -7.477M |
| June 30, 2022 | -6.317M |
| March 31, 2022 | -8.385M |
| December 31, 2021 | -5.820M |
| September 30, 2021 | -7.383M |
| June 30, 2021 | -6.517M |
| March 31, 2021 | -7.572M |
| December 31, 2020 | -3.943M |
| September 30, 2020 | -4.151M |
| June 30, 2020 | -3.488M |
| March 31, 2020 | -5.984M |
| December 31, 2019 | -3.361M |
| September 30, 2019 | -5.150M |
| June 30, 2019 | -2.494M |
| March 31, 2019 | -2.755M |
| December 31, 2018 | -1.851M |
| Date | Value |
|---|---|
| September 30, 2018 | -2.234M |
| June 30, 2018 | -2.806M |
| March 31, 2018 | -3.235M |
| December 31, 2017 | -1.943M |
| September 30, 2017 | -3.017M |
| June 30, 2017 | -5.077M |
| March 31, 2017 | -2.708M |
| December 31, 2016 | -6.553M |
| September 30, 2016 | -3.394M |
| June 30, 2016 | -3.391M |
| March 31, 2016 | -5.915M |
| December 31, 2015 | -2.601M |
| September 30, 2015 | -4.785M |
| June 30, 2015 | -5.035M |
| March 31, 2015 | -1.454M |
| December 31, 2014 | -2.067M |
| September 30, 2014 | -1.253M |
| June 30, 2014 | -0.725M |
| March 31, 2014 | 0.0078M |
| December 31, 2013 | -0.1113M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-8.385M
Minimum
Mar 2022
-2.494M
Maximum
Jun 2019
-5.506M
Average
-5.820M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
| Acasti Pharma Inc | -1.892M |
| Aurinia Pharmaceuticals Inc | 14.31M |
| Edesa Biotech Inc | -1.406M |
| Lexaria Bioscience Corp | -0.6196M |
| Xenon Pharmaceuticals Inc | -35.46M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 8.232M |
| Cash from Financing (Quarterly) | 0.1967M |
| Free Cash Flow | -22.19M |
| Free Cash Flow Per Share (Quarterly) | -0.1538 |
| Free Cash Flow Yield | -7.51% |